血栓通注射液与丹红注射液治疗急性脑梗死的临床疗效对比

Comparison of clinical efficacy on treating acute cerebral infarction with the Xueshuan Tong injection and Danhong injection

目的:对比研究血栓通注射液与丹红注射液对急性脑梗死的临床疗效。方法:将本院收治的112例急性脑梗死患者随机分为血栓通组和丹红组各56例,血栓通组采用175mg血栓通注射液溶于250ml生理盐水中进行静脉滴注,丹红组采用25ml丹红注射液溶于250ml生理盐水中进行静脉滴注,两组患者均进行2周连续治疗,治疗结束后比较两组患者的神经功能缺损评分来评价药物疗效。结果:血栓通组痊愈、显效、有效、无效及恶化患者例数分别为17、19、10、7、3,有效率为82.1%,与丹红组个疗效等级例数13、16、11、12、4及有效率71.4%%比较具有显著性差异(P<0.05)。结论:血栓通注射液与丹红注射液均对急性脑梗死具有显著疗效,但血栓通疗效更为优异,临床用药时可根据病情进行优先考虑。

Objective： To compare and study the clinical efficacy of Xueshuan Tong injection and Danhong injection on treating acute cerebral infarction. Methods： 112 patients admitted to our hospital with acute cerebral infarction, who were randomly divided into thrombotic through groups and Danhong group, 56 cases in each group, Xueshuan Tong group using the 175mg Xueshuan Tong injection dissolved in 250ml of saline intravenously, Danhong group using a 25ml Danhong injection dissolved in 250ml of normal saline intravenous infusion, continuous treatment of patients in both groups for two weeks, after the end of treatment, neurological deficit scores were compared between the two groups of patients with neurological deficit scores to evaluate medicine efficacy. Results： Xueshuan Tong group heal, effective, ineffective and deterioration in the number of patients were 17, 19, 10, 7, 3, the effective rate was 82.1%, the number of cases with Danhong efficacy level were 13, 16, 11, 12, 4 and the efficiency rate was71.4%, with a significant difference （P〈0.05）. Conclusion： Xueshuan Tong injection and Danhong injection has a significant effect on treating acute cerebral infarction but the＇, efficacy of Xueshuan Tong was better, medicine application based on patient＇s condition.